BofA/Merrill Lynch Upgrades Edwards Lifesciences (EW) to Buy
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $89.83 --0%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 22
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 22
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Buy with a price target of $130.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $108.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Etsy (ETSY) to Buy, 'Still Room to Run'
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- BofA Securities Downgrades Gerdau S.A. (GGBR4:BZ) (GGB) to Neutral
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
